FI46961C - Menetelmä terapeuttisesti aktiivisten 5-nitroimidatsolikarbamaattien v almistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten 5-nitroimidatsolikarbamaattien v almistamiseksi

Info

Publication number
FI46961C
FI46961C FI661807A FI180766A FI46961C FI 46961 C FI46961 C FI 46961C FI 661807 A FI661807 A FI 661807A FI 180766 A FI180766 A FI 180766A FI 46961 C FI46961 C FI 46961C
Authority
FI
Finland
Prior art keywords
bamates
nitroimidazole
preparation
therapeutically active
therapeutically
Prior art date
Application number
FI661807A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI46961B (es
Inventor
Carlson
Hoff
Rooney
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of FI46961B publication Critical patent/FI46961B/fi
Publication of FI46961C publication Critical patent/FI46961C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Devices For Checking Fares Or Tickets At Control Points (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI661807A 1965-07-07 1966-07-06 Menetelmä terapeuttisesti aktiivisten 5-nitroimidatsolikarbamaattien v almistamiseksi FI46961C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47023965A 1965-07-07 1965-07-07
US55093266A 1966-05-18 1966-05-18

Publications (2)

Publication Number Publication Date
FI46961B FI46961B (es) 1973-05-02
FI46961C true FI46961C (fi) 1973-08-10

Family

ID=27043018

Family Applications (1)

Application Number Title Priority Date Filing Date
FI661807A FI46961C (fi) 1965-07-07 1966-07-06 Menetelmä terapeuttisesti aktiivisten 5-nitroimidatsolikarbamaattien v almistamiseksi

Country Status (18)

Country Link
JP (3) JPS5010865B1 (es)
AT (5) AT291988B (es)
BE (1) BE683796A (es)
BR (1) BR6681050D0 (es)
CH (3) CH562806A5 (es)
CY (1) CY565A (es)
DE (1) DE1620018B2 (es)
DK (1) DK141287B (es)
ES (1) ES329085A1 (es)
FI (1) FI46961C (es)
FR (2) FR1502699A (es)
GB (5) GB1155528A (es)
IL (2) IL25931A (es)
IT (1) IT1061026B (es)
MY (1) MY7100055A (es)
NL (1) NL149793B (es)
NO (1) NO122186B (es)
SE (1) SE343578B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1280355A (en) * 1969-06-20 1972-07-05 Rech S Et D Applic Scient Et M Substituted 5-nitro-imidazoles and their preparation
BE758145A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Iso-thio-urees et derives
US3678066A (en) * 1970-03-06 1972-07-18 Squibb & Sons Inc Thiocyanic acid esters
US3968228A (en) * 1973-11-13 1976-07-06 Merck & Co., Inc. 4-Nitro-5-cyanoimidazoles as coccidiostats
JPH02254965A (ja) * 1989-03-28 1990-10-15 Chiyoudendou Hatsuden Kanren Kiki Zairyo Gijutsu Kenkyu Kumiai 超電導回転電機の回転子
PE20180175A1 (es) 2015-04-02 2018-01-22 Bayer Cropscience Ag Nuevos derivados de imidazolilmetilo 5-sustituidos
CR20190165A (es) 2016-09-29 2019-07-09 Bayer Ag Novedosos derivados de imidazolilmetilo 5-sustituidos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5149436B2 (es) * 1971-11-15 1976-12-27

Also Published As

Publication number Publication date
GB1155528A (en) 1969-06-18
SE343578B (es) 1972-03-13
AT284114B (de) 1970-09-10
GB1153347A (en) 1969-05-29
DK141287B (da) 1980-02-18
FR5890M (es) 1968-03-18
CY565A (en) 1970-11-09
GB1155530A (en) 1969-06-18
BE683796A (es) 1967-01-09
DE1620018B2 (de) 1976-04-15
FR1502699A (fr) 1967-11-24
AT291990B (de) 1971-08-10
JPS5010865B1 (es) 1975-04-24
IT1061026B (it) 1982-10-20
AT291988B (de) 1971-08-10
NO122186B (es) 1971-06-01
IL35748A0 (en) 1971-01-28
MY7100055A (en) 1971-12-31
CH522651A (de) 1972-05-15
NL149793B (nl) 1976-06-15
AT291989B (de) 1971-08-10
FI46961B (es) 1973-05-02
JPS5138718B1 (es) 1976-10-23
CH565769A5 (es) 1975-08-29
JPS4843909B1 (es) 1973-12-21
DK141287C (es) 1980-07-07
ES329085A1 (es) 1967-05-01
GB1155529A (en) 1969-06-18
BR6681050D0 (pt) 1973-05-15
AT294487B (de) 1971-11-25
CH562806A5 (es) 1975-06-13
IL25931A (en) 1972-01-27
DE1620018A1 (de) 1970-03-05
NL6609552A (es) 1967-01-09
GB1154290A (en) 1969-06-04

Similar Documents

Publication Publication Date Title
FI42712C (fi) Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
FI49035C (fi) Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi.
FI52335C (fi) Menetelmä terapeuttisesti vaikuttavien trisyklisten etyyliamiini-johda nnaisten valmistamiseksi.
FI45174C (fi) Analogiamenetelmä terapeuttisesti tehokkaan betametasoni 17-bentsoaati n valmistamiseksi.
FI45447C (fi) Menetelmä terapeuttisesti aktiivisten imidatsolijohdannaisten valmista miseksi
FI47365C (fi) Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia.
FI52857C (fi) Menetelmä terapeuttisesti vaikuttavien amidoksiimien valmistamiseksi.
FI46961C (fi) Menetelmä terapeuttisesti aktiivisten 5-nitroimidatsolikarbamaattien v almistamiseksi
FI45041C (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrroli-johdannaisten valmi stamiseksi.
FI48083C (fi) Menetelmä uusien, terapeuttisesti aktiivisten imidatsolijohdannaisten valmistamiseksi
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
FI47881C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyyliasetamidi en valmistamiseksi
FI47189C (fi) Tapa valmistaa terapeuttisesti vaikuttavia d-lysergiinihappo-N-fenyyli piperatsideja.
FI48576C (fi) Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi.
FI48833C (fi) Menetelmä terapeuttisesti käytettävien meripihkahappoimidien valmistam iseksi.
FI48190C (fi) Menetelmä terapeuttisesti aktiivisten 10alfa-metoksi-9,10-dihydroergol iinijohdannaisten valmistamiseksi
FI45045C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 5-nitro-2-furyyli-isoksa tsolijohdannaisten valmistamiseksi.
FI47100C (fi) Menetelmä terapeuttisesti vaikuttavien 1-p-klooribentsoyyli-2-alempi-a lkyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi.
FI47358C (fi) Menetelmä terapeuttisesti käytettävän 4'-demetyyli-epipodofyllotoksiin i-beta-D-glukosidin valmistamiseksi.
FI50879C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-aminoasyyliam ino-tiofeenien valmistamiseksi.
FI45954C (fi) Menetelmä terapeuttisesti vaikuttavien bentseenisulfonyylivirtsa-ainei den valmistamiseksi.
FI49162C (fi) Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.
FI48081C (fi) Menetelmä farmakologisesti aktiivisten 1-sulfanilyyli-2-imino-3-R-imid atsolidiinien valmistamiseksi
FI50243C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 3-hydroksi-9- atsamorfinaanien valmistamiseksi.